ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD
Total hemoglobin, fetal Hb increased in seven patients with transfusion-dependent ß-thalassemia, three with sickle cell disease
Prostate Cancer Pathology Not Worse With Delayed Surgery
Delayed radical prostatectomy not linked to higher risk for adverse pathological outcomes in high-risk prostate cancer
HFE Hemochromatosis May Up Risk for Liver Cancer in Men
Risk for incident primary hepatic malignancy and death increased among men with HFE p.C282Y homozygosity
Lack of Sleep Tied to Physician Burnout, Medical Errors
Risk for self-reported clinically significant medical error increases with severity of sleep impairment
Genetic Ancestry Tied to Lung Cancer Mutations in Latin Americans
Mutation frequencies of EGFR and KRAS were 30 and 10 percent, respectively, and 23 and 13 percent, respectively, for Mexican and Colombian patients
ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD
Total hemoglobin, fetal Hb increased in five patients with transfusion-dependent ß-thalassemia, two with sickle cell disease
Risk Factors for Severe COVID-19 Up in Cancer Survivors
Cancer survivors also have increased risk for influenza hospitalization/death compared with cancer-free controls
Menopause Symptoms Reduced With Higher Levels of Exercise After Cancer Tx
Findings seen for women previously treated with menopause-inducing cancer treatments
Hospitalization Up for Black Gynecologic Cancer Patients With COVID-19
Among patients with gynecologic cancer who died from COVID-19, 41.2 percent were Black
ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL
Phase 2 study reveals high objective response rate for CAR T-cell therapy in patients with follicular lymphoma, marginal zone lymphoma
